NovoCure (NVCR) EPS (Basic) Growth (1y) (2015 - 2026)
NovoCure (NVCR) EPS (Basic) Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | -47.75% |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 43.85% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 18.90% |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 14.55% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -25.84% |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 42.13% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 72.17% |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 13.85% |
| 10 | NovoCure | 2.05 Bn | 1.61 Bn | 142.48 Mn | 62.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 62.48% |
| Mar 31, 2026 | -100.26% |
| Dec 31, 2025 | 64.05% |
| Sep 30, 2025 | -17.93% |
| Jun 30, 2025 | -16.09% |
| Mar 31, 2025 | 13.88% |
| Dec 31, 2024 | -38.15% |
| Sep 30, 2024 | 39.07% |
| Jun 30, 2024 | 42.64% |
| Mar 31, 2024 | 28.04% |
| Dec 31, 2023 | -24.15% |
| Sep 30, 2023 | -82.91% |
| Jun 30, 2023 | -135.42% |
| Mar 31, 2023 | -1,025.83% |
| Dec 31, 2022 | -39.34% |
| Sep 30, 2022 | -100.27% |
| Jun 30, 2022 | -62.19% |
| Mar 31, 2022 | -10.90% |
| Dec 31, 2021 | -625.07% |
| Sep 30, 2021 | -237.96% |